Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.42 |
| ▸ | CA7 | P43166 | 4/20 | 0.42 |
| ▸ | CA9 | Q16790 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | LTA4H | P09960 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | AKT1 | P31749 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7568911 | 0.86 | TOP2A (0.52) | SMN1; SMN2ALDH1A1LTA4H | |
| SCHEMBL3121567 | 0.79 | FFAR1 (0.34) | SMN1; SMN2ALDH1A1HTTKMT2AHSD17B10 | |
| SCHEMBL3769269 | 0.79 | ALDH1A1 (0.53) | SMN1; SMN2LMNAALDH1A1MAPTHTT | |
| SCHEMBL3126679 | 0.77 | LMNA (0.38) | CA12CA9CA1LMNAALDH1A1 | |
| SCHEMBL7565859 | 0.76 | KDM4E (0.44) | SMN1; SMN2LMNAALDH1A1HTTKMT2A | |
| SCHEMBL7802304 | 0.76 | KCNH3 (0.42) | SMN1; SMN2LMNAALDH1A1HSD17B10KDM4E | |
| SCHEMBL505867 | 0.74 | LMNA (0.55) | CA12CA14CA7CA9SMN1; SMN2 | |
| SCHEMBL3121594 | 0.74 | ALDH1A1 (0.37) | SMN1; SMN2ALDH1A1HTT | |
| SCHEMBL998675 | 0.73 | ALDH1A1 (0.46) | CA12CA14CA7CA9SMN1; SMN2 | |
| SCHEMBL1355267 | 0.73 | KDM4E (0.42) | LMNAALDH1A1MAPTKMT2ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010012899-A1 | Oligomeric methine dyes | CLARIANT FINANCE ( BVI) LIMITED | 2001-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010012899-A1 | Oligomeric methine dyes | INMT, DDT, DDC | CA12 3186/4885CA14 3279/4885CA7 2516/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.